Novel therapy development for chronic sinusitis may be promoted by a new targetAccording to researchers at the Johns Hopkins, a protein that is known to stimulate growth of blood vessel is responsible for the cell overgrowth in polyps’ development signifying one of the most severe forms of sinusitis.

It is considered by many scientists that this result finding will be more than helpful when it comes to developing novel therapies to treat this disease form that typically resists all current treatments.

The findings suggest that medical practitioners could treat sinusitis in patients with polyps by making use of therapies that minimize VEGF (vascular endothelial growth factor) in sinus tissues.